Nouveau Life Pharmaceuticals, Inc. (NOUV)

USD 0.0

(-50.0%)

Market Cap (In USD)

90 Thousand

Revenue (In USD)

-

Net Income (In USD)

-

Avg. Volume

3.78 Million

Currency
USD
Country
Financial Services
Open
-
Prev. Close
-
Day Range
-
Year Range
5.0E-5-3.0E-4
PE
-
EPS
-
Beta Value
-0.436
ISIN
US66979K1034
CUSIP
66979K103
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Financial Services
Industry
Shell Companies
CEO
Mr. Brian Shibley
Employee Count
-
Website
-
Ipo Date
2003-02-21
Details
Nouveau Life Pharmaceuticals, Inc., a development stage company, engages in the development of nutraceuticals products. It provides natural alternatives and prescription drugs. The company was formerly known as Hybrid Fuels, Inc. and changed its name to Nouveau Life Pharmaceuticals, Inc. in May 2012. Nouveau Life Pharmaceuticals, Inc. was incorporated in 1998 and is based in Ft. Lauderdale, Florida. Nouveau Life Pharmaceuticals, Inc. operates as a subsidiary of EMG Marketing Solutions, Inc.